Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer

NCT04552769 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Cancer
Anaplastic Thyroid Cancer
Undifferentiated Thyroid Cancer

Interventions

DRUG: Abemaciclib

Sponsor

Stanford University